Device for treating diseases in patients with acute renal failure (ARF) and acute inflammation induced by cardio pulmonary bypass (CPB) surgery, to produce improvement in survival rates and reduce costs
Start Trial Get Full Profile
There’s no risk. Start your trial today to see profiles of CytoPherx plus 4840 other startups.
